MÓNICA
DÍAZ GAVILÁN
PROFESORA TITULAR DE UNIVERSIDAD
Universidad de Jaén
Jaén, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad de Jaén (7)
2022
2021
-
Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias
Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-31
2012
-
The selective cytotoxic activity in breast cancer cells by an anthranilic alcohol-derived acyclic 5-fluorouracil O,N-acetal is mediated by endoplasmic reticulum stress-induced apoptosis
European Journal of Medicinal Chemistry, Vol. 50, pp. 376-382
2008
-
Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies
Bioorganic and Medicinal Chemistry Letters, Vol. 18, Núm. 4, pp. 1457-1460
-
Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin- 3-ylmethyl)-9H-purines
ChemMedChem, Vol. 3, Núm. 1, pp. 127-135
2007
-
A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells
Breast Cancer Research and Treatment, Vol. 105, Núm. 3, pp. 237-246
2006
-
Synthesis and anticancer activity studies of novel 1-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)uracil and (6′-substituted)-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or 9H-purines
Tetrahedron, Vol. 62, Núm. 50, pp. 11724-11733